GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mecp2
|
ENSRNOG00000056659 | methyl CpG binding protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Mecp2 | rn6_v1_chrX_+_156655960_156655960 | 0.38 | 1.8e-12 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_127271289 | 71.62 |
ENSRNOT00000015113
|
Itga9
|
integrin subunit alpha 9 |
chr10_-_11174861 | 56.57 |
ENSRNOT00000006680
|
Glis2
|
GLIS family zinc finger 2 |
chr7_-_142260896 | 54.15 |
ENSRNOT00000073536
|
Smagp
|
small cell adhesion glycoprotein |
chr18_-_48384645 | 52.82 |
ENSRNOT00000023485
|
Ppic
|
peptidylprolyl isomerase C |
chr9_-_81400987 | 52.78 |
ENSRNOT00000035277
|
Tns1
|
tensin 1 |
chr3_-_51297852 | 51.52 |
ENSRNOT00000001607
|
Cobll1
|
cordon-bleu WH2 repeat protein-like 1 |
chr7_+_130474508 | 51.32 |
ENSRNOT00000085191
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr11_+_82466071 | 50.30 |
ENSRNOT00000036958
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chrX_-_157139291 | 49.66 |
ENSRNOT00000092123
|
Slc6a8
|
solute carrier family 6 member 8 |
chr10_+_84182118 | 49.61 |
ENSRNOT00000011027
|
Hoxb3
|
homeo box B3 |
chr3_-_175601127 | 46.54 |
ENSRNOT00000081226
|
Lama5
|
laminin subunit alpha 5 |
chr6_+_49968473 | 44.87 |
ENSRNOT00000007466
|
Fam110c
|
family with sequence similarity 110, member C |
chr3_+_45683993 | 44.29 |
ENSRNOT00000038983
|
Tanc1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
chr10_-_64202380 | 43.63 |
ENSRNOT00000008982
|
Rflnb
|
refilin B |
chr8_+_99977334 | 41.37 |
ENSRNOT00000085808
ENSRNOT00000056704 ENSRNOT00000041859 |
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
chr1_+_150797084 | 41.30 |
ENSRNOT00000018990
|
Nox4
|
NADPH oxidase 4 |
chr17_-_19703681 | 41.26 |
ENSRNOT00000024021
|
Mylip
|
myosin regulatory light chain interacting protein |
chr10_+_86367596 | 40.42 |
ENSRNOT00000049070
ENSRNOT00000009114 ENSRNOT00000078744 |
Erbb2
|
erb-b2 receptor tyrosine kinase 2 |
chr6_-_25616995 | 39.50 |
ENSRNOT00000077894
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit |
chr7_+_130474279 | 39.47 |
ENSRNOT00000092388
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr4_-_66380734 | 38.74 |
ENSRNOT00000009194
|
Klrg2
|
killer cell lectin like receptor G2 |
chr8_-_87158368 | 38.37 |
ENSRNOT00000077071
|
Col12a1
|
collagen type XII alpha 1 chain |
chr5_+_133221139 | 37.84 |
ENSRNOT00000047522
|
Trabd2b
|
TraB domain containing 2B |
chr7_-_23594133 | 37.12 |
ENSRNOT00000005746
|
Timp3
|
TIMP metallopeptidase inhibitor 3 |
chr1_+_221099998 | 35.92 |
ENSRNOT00000028262
|
Ltbp3
|
latent transforming growth factor beta binding protein 3 |
chr3_-_55822551 | 35.90 |
ENSRNOT00000082624
|
Lrp2
|
LDL receptor related protein 2 |
chr20_-_14020007 | 35.86 |
ENSRNOT00000093521
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr4_+_175431904 | 35.67 |
ENSRNOT00000032843
|
Pde3a
|
phosphodiesterase 3A |
chr1_+_219233750 | 35.28 |
ENSRNOT00000024112
|
Acy3
|
aminoacylase 3 |
chr7_-_144993652 | 34.93 |
ENSRNOT00000087748
|
Itga5
|
integrin subunit alpha 5 |
chr1_-_82120902 | 34.72 |
ENSRNOT00000027684
|
Erf
|
Ets2 repressor factor |
chr10_+_63803309 | 34.61 |
ENSRNOT00000036666
|
Myo1c
|
myosin 1C |
chr8_+_71168097 | 34.19 |
ENSRNOT00000081375
|
Rbpms2
|
RNA binding protein with multiple splicing 2 |
chr1_+_242959488 | 33.83 |
ENSRNOT00000015668
|
Dock8
|
dedicator of cytokinesis 8 |
chr7_-_3010350 | 32.84 |
ENSRNOT00000006796
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3 |
chr7_+_130498199 | 32.66 |
ENSRNOT00000092684
ENSRNOT00000092431 |
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr11_-_70322690 | 32.58 |
ENSRNOT00000002443
|
Heg1
|
heart development protein with EGF-like domains 1 |
chr6_-_21600451 | 32.36 |
ENSRNOT00000047674
|
Ltbp1
|
latent transforming growth factor beta binding protein 1 |
chr16_-_22561496 | 32.18 |
ENSRNOT00000016543
|
Lpl
|
lipoprotein lipase |
chr3_+_6430201 | 32.11 |
ENSRNOT00000086352
|
Col5a1
|
collagen type V alpha 1 chain |
chr8_-_55408464 | 32.06 |
ENSRNOT00000066893
|
Sik2
|
salt-inducible kinase 2 |
chr14_+_33010300 | 31.87 |
ENSRNOT00000002809
|
Igfbp7
|
insulin-like growth factor binding protein 7 |
chr10_-_88874528 | 31.77 |
ENSRNOT00000026783
|
Ptrf
|
polymerase I and transcript release factor |
chr6_+_788548 | 31.65 |
ENSRNOT00000005983
|
Crim1
|
cysteine rich transmembrane BMP regulator 1 |
chr8_-_33661049 | 31.59 |
ENSRNOT00000068037
|
Fli1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr1_+_128924966 | 30.83 |
ENSRNOT00000019267
|
Igf1r
|
insulin-like growth factor 1 receptor |
chr1_+_56242346 | 30.29 |
ENSRNOT00000019317
|
Smoc2
|
SPARC related modular calcium binding 2 |
chr4_-_66624912 | 30.12 |
ENSRNOT00000064891
|
Hipk2
|
homeodomain interacting protein kinase 2 |
chr13_+_34610684 | 29.82 |
ENSRNOT00000093019
ENSRNOT00000003280 |
Tfcp2l1
|
transcription factor CP2-like 1 |
chr11_+_87722350 | 29.81 |
ENSRNOT00000000313
|
Scarf2
|
scavenger receptor class F, member 2 |
chr5_-_152762165 | 29.45 |
ENSRNOT00000022921
|
Selenon
|
selenoprotein N |
chr8_+_115069095 | 29.44 |
ENSRNOT00000014770
|
Dusp7
|
dual specificity phosphatase 7 |
chr20_+_22913694 | 29.37 |
ENSRNOT00000067920
|
Reep3
|
receptor accessory protein 3 |
chr2_-_204625743 | 29.33 |
ENSRNOT00000022182
|
Vangl1
|
VANGL planar cell polarity protein 1 |
chr15_-_82482009 | 29.31 |
ENSRNOT00000011926
|
Dach1
|
dachshund family transcription factor 1 |
chr1_+_33910912 | 29.31 |
ENSRNOT00000044690
|
Irx1
|
iroquois homeobox 1 |
chr10_+_89167146 | 29.12 |
ENSRNOT00000043953
|
Ramp2
|
receptor activity modifying protein 2 |
chr3_+_80362858 | 29.10 |
ENSRNOT00000021353
ENSRNOT00000086242 |
Lrp4
|
LDL receptor related protein 4 |
chr1_-_153740905 | 29.01 |
ENSRNOT00000023239
|
Prss23
|
protease, serine, 23 |
chr9_+_81672758 | 28.87 |
ENSRNOT00000020646
|
Ctdsp1
|
CTD small phosphatase 1 |
chr2_-_28801223 | 28.74 |
ENSRNOT00000020726
|
Tmem171
|
transmembrane protein 171 |
chr5_+_80920568 | 28.63 |
ENSRNOT00000076467
ENSRNOT00000076111 ENSRNOT00000040898 |
Pappa
|
pregnancy-associated plasma protein A |
chr1_+_32221636 | 28.56 |
ENSRNOT00000022346
ENSRNOT00000089941 |
Slc6a18
|
solute carrier family 6 member 18 |
chr12_+_17735740 | 28.53 |
ENSRNOT00000001775
|
Pdgfa
|
platelet derived growth factor subunit A |
chr11_-_25456836 | 28.49 |
ENSRNOT00000085444
|
Adamts5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr2_-_203494391 | 28.21 |
ENSRNOT00000021162
|
Ptgfrn
|
prostaglandin F2 receptor inhibitor |
chr3_-_5975734 | 28.01 |
ENSRNOT00000081376
|
Vav2
|
vav guanine nucleotide exchange factor 2 |
chr2_+_189169877 | 27.99 |
ENSRNOT00000028225
|
She
|
Src homology 2 domain containing E |
chr19_+_23389375 | 27.97 |
ENSRNOT00000018629
|
Sall1
|
spalt-like transcription factor 1 |
chr16_+_83522162 | 27.86 |
ENSRNOT00000057386
|
Col4a1
|
collagen type IV alpha 1 chain |
chr5_-_114014277 | 27.84 |
ENSRNOT00000011731
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit |
chr10_+_73279119 | 27.79 |
ENSRNOT00000004698
|
Tbx2
|
T-box 2 |
chr17_-_13812615 | 27.79 |
ENSRNOT00000019473
ENSRNOT00000085581 |
S1pr3
|
sphingosine-1-phosphate receptor 3 |
chr6_+_48866601 | 27.75 |
ENSRNOT00000077321
ENSRNOT00000079891 |
Pxdn
|
peroxidasin |
chr11_-_38103290 | 27.70 |
ENSRNOT00000066413
|
Tmprss2
|
transmembrane protease, serine 2 |
chr15_+_33108671 | 27.54 |
ENSRNOT00000015468
|
Lrp10
|
LDL receptor related protein 10 |
chr6_+_24160226 | 27.32 |
ENSRNOT00000091904
|
Lbh
|
limb bud and heart development |
chr1_-_146289465 | 27.31 |
ENSRNOT00000017362
|
Abhd17c
|
abhydrolase domain containing 17C |
chr16_-_19777414 | 27.18 |
ENSRNOT00000022898
|
Nr2f6
|
nuclear receptor subfamily 2, group F, member 6 |
chr8_-_68966108 | 27.12 |
ENSRNOT00000012155
|
Smad6
|
SMAD family member 6 |
chr11_-_67037115 | 26.97 |
ENSRNOT00000003137
|
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr10_+_106065712 | 26.89 |
ENSRNOT00000003690
|
Sec14l1
|
SEC14-like lipid binding 1 |
chr5_+_59128315 | 26.87 |
ENSRNOT00000021802
|
Npr2
|
natriuretic peptide receptor 2 |
chr1_-_47331412 | 26.57 |
ENSRNOT00000046746
|
Ezr
|
ezrin |
chr7_-_139254551 | 26.56 |
ENSRNOT00000083182
|
Rapgef3
|
Rap guanine nucleotide exchange factor 3 |
chr2_+_251634431 | 26.49 |
ENSRNOT00000045016
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1 |
chr7_+_126619196 | 26.14 |
ENSRNOT00000030082
|
Ppara
|
peroxisome proliferator activated receptor alpha |
chr7_+_42269784 | 25.94 |
ENSRNOT00000008471
ENSRNOT00000007231 |
Kitlg
|
KIT ligand |
chr7_-_126913585 | 25.70 |
ENSRNOT00000036025
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 |
chr3_-_156340913 | 25.56 |
ENSRNOT00000021452
|
Mafb
|
MAF bZIP transcription factor B |
chr8_-_13109487 | 25.54 |
ENSRNOT00000061616
|
Amotl1
|
angiomotin-like 1 |
chr8_-_97647072 | 25.53 |
ENSRNOT00000030645
|
Tbc1d2b
|
TBC1 domain family, member 2B |
chr19_+_18079094 | 25.53 |
ENSRNOT00000029415
|
Tox3
|
TOX high mobility group box family member 3 |
chr10_+_15672382 | 25.48 |
ENSRNOT00000027965
|
Rhbdf1
|
rhomboid 5 homolog 1 |
chr10_+_89166890 | 25.46 |
ENSRNOT00000088331
|
Ramp2
|
receptor activity modifying protein 2 |
chr1_-_141893674 | 25.43 |
ENSRNOT00000019059
ENSRNOT00000085988 |
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2, mitochondrial |
chr7_-_139318455 | 25.39 |
ENSRNOT00000092029
|
Hdac7
|
histone deacetylase 7 |
chr1_-_131454689 | 25.34 |
ENSRNOT00000014152
|
Nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr9_-_19372673 | 25.26 |
ENSRNOT00000073667
ENSRNOT00000079517 |
Clic5
|
chloride intracellular channel 5 |
chr14_-_20816588 | 25.25 |
ENSRNOT00000033806
|
Slc4a4
|
solute carrier family 4 member 4 |
chr3_-_152222647 | 25.08 |
ENSRNOT00000026820
|
Nfs1
|
NFS1 cysteine desulfurase |
chr13_-_70174565 | 24.98 |
ENSRNOT00000067135
|
Rgl1
|
ral guanine nucleotide dissociation stimulator,-like 1 |
chr12_-_22726982 | 24.86 |
ENSRNOT00000001921
|
Plod3
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
chr18_+_65814026 | 24.84 |
ENSRNOT00000016112
|
Mbd2
|
methyl-CpG binding domain protein 2 |
chr3_-_151688149 | 24.81 |
ENSRNOT00000072945
|
Nfs1
|
NFS1 cysteine desulfurase |
chr20_+_44680449 | 24.77 |
ENSRNOT00000000728
|
Traf3ip2
|
Traf3 interacting protein 2 |
chr20_+_33359196 | 24.47 |
ENSRNOT00000000462
|
Dcbld1
|
discoidin, CUB and LCCL domain containing 1 |
chr14_+_3506339 | 24.28 |
ENSRNOT00000002867
|
Tgfbr3
|
transforming growth factor beta receptor 3 |
chr16_-_71319449 | 24.27 |
ENSRNOT00000029284
|
Fgfr1
|
Fibroblast growth factor receptor 1 |
chr16_-_73410777 | 24.25 |
ENSRNOT00000024128
|
Sfrp1
|
secreted frizzled-related protein 1 |
chr8_-_21995806 | 23.94 |
ENSRNOT00000028034
|
S1pr2
|
sphingosine-1-phosphate receptor 2 |
chr1_+_177495782 | 23.92 |
ENSRNOT00000021020
|
Tead1
|
TEA domain transcription factor 1 |
chr1_+_221673590 | 23.86 |
ENSRNOT00000038016
|
Cdc42bpg
|
CDC42 binding protein kinase gamma |
chr17_+_30556884 | 23.84 |
ENSRNOT00000080929
ENSRNOT00000022022 |
Eci2
|
enoyl-CoA delta isomerase 2 |
chr17_+_62262129 | 23.52 |
ENSRNOT00000073575
|
Fzd8
|
frizzled class receptor 8 |
chr5_-_172623899 | 23.51 |
ENSRNOT00000080591
|
Ski
|
SKI proto-oncogene |
chr10_+_4719713 | 23.48 |
ENSRNOT00000003412
|
Litaf
|
lipopolysaccharide-induced TNF factor |
chr7_+_144628120 | 23.39 |
ENSRNOT00000022247
|
Hoxc5
|
homeo box C5 |
chr3_-_9262628 | 23.39 |
ENSRNOT00000013286
|
Aif1l
|
allograft inflammatory factor 1-like |
chr4_-_58893170 | 23.37 |
ENSRNOT00000077406
|
Podxl
|
podocalyxin-like |
chr10_+_13723405 | 23.34 |
ENSRNOT00000072789
|
Abca3
|
ATP binding cassette subfamily A member 3 |
chr14_+_78213635 | 23.32 |
ENSRNOT00000010541
|
Evc
|
EvC ciliary complex subunit 1 |
chr12_+_17736287 | 23.31 |
ENSRNOT00000091476
|
Pdgfa
|
platelet derived growth factor subunit A |
chr15_-_47800024 | 23.28 |
ENSRNOT00000072997
ENSRNOT00000016616 |
Msra
|
methionine sulfoxide reductase A |
chr5_+_56425024 | 23.23 |
ENSRNOT00000008337
|
Aco1
|
aconitase 1 |
chr1_-_89084859 | 23.19 |
ENSRNOT00000032026
|
Cox6b1
|
cytochrome c oxidase subunit 6B1 |
chr1_-_267245636 | 23.15 |
ENSRNOT00000082799
|
Sh3pxd2a
|
SH3 and PX domains 2A |
chr3_-_149905944 | 22.93 |
ENSRNOT00000021715
|
Snta1
|
syntrophin, alpha 1 |
chr1_+_32199810 | 22.92 |
ENSRNOT00000036714
|
Slc6a19
|
solute carrier family 6 member 19 |
chr19_-_15840990 | 22.92 |
ENSRNOT00000015583
|
Irx3
|
iroquois homeobox 3 |
chr6_-_44361908 | 22.88 |
ENSRNOT00000009491
|
Id2
|
inhibitor of DNA binding 2, HLH protein |
chr2_-_147693082 | 22.73 |
ENSRNOT00000022507
|
Wwtr1
|
WW domain containing transcription regulator 1 |
chr8_+_48805684 | 22.59 |
ENSRNOT00000064041
|
Bcl9l
|
B-cell CLL/lymphoma 9-like |
chr17_+_83221827 | 22.58 |
ENSRNOT00000000155
|
Plxdc2
|
plexin domain containing 2 |
chr4_-_82173207 | 22.56 |
ENSRNOT00000074167
|
Hoxa5
|
homeo box A5 |
chr14_-_87465374 | 22.47 |
ENSRNOT00000088355
|
Igfbp3
|
insulin-like growth factor binding protein 3 |
chr5_-_134207847 | 22.47 |
ENSRNOT00000083686
ENSRNOT00000088209 ENSRNOT00000051252 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr9_-_73871888 | 22.41 |
ENSRNOT00000017686
|
Acadl
|
acyl-CoA dehydrogenase, long chain |
chr8_+_50310405 | 22.26 |
ENSRNOT00000073507
|
Sik3
|
SIK family kinase 3 |
chr12_-_16934706 | 22.12 |
ENSRNOT00000001720
|
Mafk
|
MAF bZIP transcription factor K |
chr3_-_130114770 | 22.08 |
ENSRNOT00000010638
|
Jag1
|
jagged 1 |
chr9_-_9985630 | 22.06 |
ENSRNOT00000071780
|
Crb3
|
crumbs 3, cell polarity complex component |
chr16_-_19399851 | 22.04 |
ENSRNOT00000089056
ENSRNOT00000021073 |
Tpm4
|
tropomyosin 4 |
chr4_-_157829241 | 22.02 |
ENSRNOT00000026184
|
Ltbr
|
lymphotoxin beta receptor |
chr5_-_152920343 | 21.90 |
ENSRNOT00000022956
|
Man1c1
|
mannosidase, alpha, class 1C, member 1 |
chr1_+_15412603 | 21.87 |
ENSRNOT00000051496
ENSRNOT00000067070 |
Map3k5
|
mitogen-activated protein kinase kinase kinase 5 |
chr8_+_122439328 | 21.77 |
ENSRNOT00000013632
|
Glb1
|
galactosidase, beta 1 |
chr1_+_137014272 | 21.67 |
ENSRNOT00000014802
|
Akap13
|
A-kinase anchoring protein 13 |
chr5_-_173081839 | 21.66 |
ENSRNOT00000066880
|
Mmp23
|
matrix metallopeptidase 23 |
chr4_-_58875753 | 21.63 |
ENSRNOT00000016991
|
Podxl
|
podocalyxin-like |
chr15_-_51855325 | 21.59 |
ENSRNOT00000011663
|
Pdlim2
|
PDZ and LIM domain 2 |
chr14_+_34727915 | 21.57 |
ENSRNOT00000085089
|
Kdr
|
kinase insert domain receptor |
chr16_-_71319052 | 21.52 |
ENSRNOT00000050980
|
Fgfr1
|
Fibroblast growth factor receptor 1 |
chr10_+_71159869 | 21.47 |
ENSRNOT00000075977
ENSRNOT00000047427 |
Hnf1b
|
HNF1 homeobox B |
chr10_+_84718824 | 21.42 |
ENSRNOT00000055464
|
Copz2
|
coatomer protein complex, subunit zeta 2 |
chr9_+_20264418 | 21.38 |
ENSRNOT00000051841
|
Atn1
|
atrophin 1 |
chr5_+_159845774 | 21.32 |
ENSRNOT00000012328
|
Epha2
|
Eph receptor A2 |
chr5_-_156141537 | 21.28 |
ENSRNOT00000019004
|
Alpl
|
alkaline phosphatase, liver/bone/kidney |
chr15_-_18882959 | 21.26 |
ENSRNOT00000066546
ENSRNOT00000088264 |
Flnb
|
filamin B |
chr6_+_109466060 | 21.26 |
ENSRNOT00000011339
|
Jdp2
|
Jun dimerization protein 2 |
chr3_+_71114100 | 21.12 |
ENSRNOT00000088549
ENSRNOT00000006961 |
Itgav
|
integrin subunit alpha V |
chr13_-_50916982 | 21.08 |
ENSRNOT00000004408
|
Btg2
|
BTG anti-proliferation factor 2 |
chr14_-_16979760 | 21.02 |
ENSRNOT00000003020
|
Stbd1
|
starch binding domain 1 |
chr5_+_167952728 | 21.02 |
ENSRNOT00000085315
|
Errfi1
|
ERBB receptor feedback inhibitor 1 |
chr15_+_24942218 | 20.95 |
ENSRNOT00000016629
|
Peli2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr3_-_173953684 | 20.93 |
ENSRNOT00000090468
|
Ppp1r3d
|
protein phosphatase 1, regulatory subunit 3D |
chr9_-_38495126 | 20.90 |
ENSRNOT00000016933
ENSRNOT00000090385 |
Rab23
|
RAB23, member RAS oncogene family |
chr17_-_31569904 | 20.90 |
ENSRNOT00000023962
|
Ripk1
|
receptor interacting serine/threonine kinase 1 |
chr12_+_943006 | 20.89 |
ENSRNOT00000001449
|
Kl
|
Klotho |
chr5_-_151856256 | 20.79 |
ENSRNOT00000081470
|
Zdhhc18
|
zinc finger, DHHC-type containing 18 |
chr7_+_53630621 | 20.66 |
ENSRNOT00000067011
ENSRNOT00000080598 |
Csrp2
|
cysteine and glycine-rich protein 2 |
chr4_-_147893992 | 20.60 |
ENSRNOT00000032158
|
Plxnd1
|
plexin D1 |
chr14_-_7325645 | 20.48 |
ENSRNOT00000066071
|
Aff1
|
AF4/FMR2 family, member 1 |
chr13_-_110077946 | 20.48 |
ENSRNOT00000000078
|
Ppp2r5a
|
protein phosphatase 2, regulatory subunit B', alpha |
chr10_+_5433248 | 20.38 |
ENSRNOT00000003615
|
Emp2
|
epithelial membrane protein 2 |
chr8_-_47404010 | 20.37 |
ENSRNOT00000038647
|
Tmem136
|
transmembrane protein 136 |
chr1_-_218920094 | 20.33 |
ENSRNOT00000022213
|
Lrp5
|
LDL receptor related protein 5 |
chr8_+_99625545 | 20.29 |
ENSRNOT00000010689
ENSRNOT00000056727 |
Plscr1
|
phospholipid scramblase 1 |
chr2_-_142885604 | 20.12 |
ENSRNOT00000031487
|
Frem2
|
Fras1 related extracellular matrix protein 2 |
chr5_-_153625869 | 20.10 |
ENSRNOT00000024464
|
Clic4
|
chloride intracellular channel 4 |
chr4_-_100660140 | 20.09 |
ENSRNOT00000020005
|
Tcf7l1
|
transcription factor 7 like 1 |
chr10_+_89181180 | 20.06 |
ENSRNOT00000078931
ENSRNOT00000027770 |
Wnk4
|
WNK lysine deficient protein kinase 4 |
chr6_-_103313074 | 20.04 |
ENSRNOT00000083677
|
Zfp36l1
|
zinc finger protein 36, C3H type-like 1 |
chr20_+_55594676 | 19.98 |
ENSRNOT00000057010
|
Sim1
|
single-minded family bHLH transcription factor 1 |
chr8_-_6203515 | 19.97 |
ENSRNOT00000087278
ENSRNOT00000031189 ENSRNOT00000008074 ENSRNOT00000085285 ENSRNOT00000007866 |
Yap1
|
yes-associated protein 1 |
chr1_-_193328371 | 19.93 |
ENSRNOT00000019304
ENSRNOT00000031770 ENSRNOT00000019309 |
Arhgap17
|
Rho GTPase activating protein 17 |
chr20_+_7484550 | 19.89 |
ENSRNOT00000044395
|
Anks1a
|
ankyrin repeat and sterile alpha motif domain containing 1A |
chr7_-_51353068 | 19.89 |
ENSRNOT00000008222
|
Pawr
|
pro-apoptotic WT1 regulator |
chr10_+_35726544 | 19.87 |
ENSRNOT00000004323
|
Mgat4b
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
chr19_-_37303788 | 19.71 |
ENSRNOT00000084734
|
Fhod1
|
formin homology 2 domain containing 1 |
chr10_-_56558487 | 19.63 |
ENSRNOT00000023256
|
Slc2a4
|
solute carrier family 2 member 4 |
chr10_+_109665682 | 19.58 |
ENSRNOT00000054963
|
Slc25a10
|
solute carrier family 25 member 10 |
chr20_-_4943564 | 19.58 |
ENSRNOT00000049310
|
RT1-CE1
|
RT1 class I, locus1 |
chr17_-_24182425 | 19.57 |
ENSRNOT00000024206
|
Mcur1
|
mitochondrial calcium uniporter regulator 1 |
chr5_-_173622645 | 19.54 |
ENSRNOT00000045678
|
Agrn
|
agrin |
chr10_-_39373437 | 19.52 |
ENSRNOT00000058907
|
Slc22a5
|
solute carrier family 22 member 5 |
chr10_-_91448477 | 19.50 |
ENSRNOT00000038836
|
Arhgap27
|
Rho GTPase activating protein 27 |
chr5_+_2813131 | 19.47 |
ENSRNOT00000009530
|
Sbspon
|
somatomedin B and thrombospondin, type 1 domain containing |
chr10_+_84167331 | 19.41 |
ENSRNOT00000010965
|
Hoxb4
|
homeo box B4 |
chr14_+_34727623 | 19.39 |
ENSRNOT00000071405
ENSRNOT00000090183 |
Kdr
|
kinase insert domain receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
35.9 | 35.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
24.7 | 123.4 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
22.1 | 66.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
20.6 | 61.7 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
18.9 | 56.6 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
17.3 | 51.8 | GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling(GO:0060683) embryonic lung development(GO:1990401) |
17.1 | 51.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
17.1 | 51.2 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
15.5 | 93.0 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
15.4 | 46.1 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
15.3 | 15.3 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
14.6 | 58.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
14.4 | 43.1 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
14.1 | 14.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
14.0 | 42.1 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
13.8 | 13.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
13.8 | 41.5 | GO:1901220 | regulation of cardiac chamber morphogenesis(GO:1901219) negative regulation of cardiac chamber morphogenesis(GO:1901220) |
13.1 | 52.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
12.9 | 12.9 | GO:0072554 | blood vessel lumenization(GO:0072554) |
12.9 | 38.6 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
12.3 | 37.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
12.3 | 49.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
12.1 | 24.3 | GO:0010159 | specification of organ position(GO:0010159) |
12.1 | 24.2 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
12.1 | 60.5 | GO:0044691 | tooth eruption(GO:0044691) |
12.0 | 36.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
11.2 | 67.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
10.9 | 10.9 | GO:0061349 | planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
10.5 | 21.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
10.4 | 41.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
10.3 | 82.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
10.2 | 20.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
10.2 | 30.7 | GO:0060849 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
10.0 | 50.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
10.0 | 40.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
9.8 | 39.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
9.8 | 39.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
9.7 | 29.2 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
9.7 | 29.2 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
9.6 | 38.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
9.5 | 18.9 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
9.4 | 47.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
9.4 | 65.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
9.3 | 37.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
9.2 | 55.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
9.2 | 36.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
9.1 | 27.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
9.1 | 27.2 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
9.1 | 27.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
9.1 | 72.5 | GO:0015871 | choline transport(GO:0015871) |
9.0 | 27.0 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
9.0 | 35.9 | GO:0031179 | peptide modification(GO:0031179) |
8.9 | 26.7 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
8.8 | 61.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
8.8 | 17.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
8.8 | 26.3 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
8.7 | 17.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
8.6 | 17.3 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
8.6 | 17.2 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
8.6 | 34.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
8.6 | 25.7 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
8.5 | 25.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
8.5 | 34.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
8.5 | 42.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
8.4 | 16.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
8.4 | 33.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
8.3 | 24.9 | GO:0001966 | thigmotaxis(GO:0001966) |
8.3 | 16.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
8.3 | 16.5 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
8.2 | 16.3 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
8.1 | 89.4 | GO:0060242 | contact inhibition(GO:0060242) |
8.1 | 24.3 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
8.0 | 8.0 | GO:0018307 | enzyme active site formation(GO:0018307) |
7.9 | 23.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
7.9 | 15.8 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
7.9 | 15.8 | GO:0003192 | mitral valve formation(GO:0003192) |
7.8 | 31.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
7.8 | 46.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
7.7 | 30.8 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
7.7 | 7.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
7.4 | 7.4 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
7.4 | 22.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
7.4 | 22.2 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
7.4 | 22.1 | GO:0061443 | endocardial cushion cell differentiation(GO:0061443) |
7.4 | 29.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
7.3 | 43.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
7.3 | 21.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
7.2 | 21.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
7.2 | 21.5 | GO:0061206 | mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
7.2 | 21.5 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
7.1 | 28.6 | GO:1904387 | cellular response to L-phenylalanine derivative(GO:1904387) |
7.1 | 14.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
7.1 | 21.3 | GO:0071529 | cementum mineralization(GO:0071529) |
7.1 | 21.2 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
7.0 | 21.0 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
7.0 | 41.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
7.0 | 20.9 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
6.9 | 6.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
6.9 | 55.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
6.9 | 34.3 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
6.8 | 20.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
6.8 | 13.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
6.7 | 33.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
6.7 | 47.0 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
6.7 | 13.3 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
6.6 | 26.6 | GO:1902896 | terminal web assembly(GO:1902896) |
6.6 | 26.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
6.6 | 6.6 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) |
6.5 | 19.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
6.5 | 19.5 | GO:1901723 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) negative regulation of cell proliferation involved in kidney development(GO:1901723) |
6.5 | 38.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
6.4 | 25.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
6.4 | 19.1 | GO:0030091 | protein repair(GO:0030091) |
6.3 | 19.0 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
6.3 | 18.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
6.2 | 24.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
6.2 | 24.8 | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
6.2 | 18.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
6.1 | 18.3 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
6.0 | 12.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
5.9 | 17.8 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
5.9 | 23.6 | GO:0042891 | antibiotic transport(GO:0042891) |
5.9 | 17.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.9 | 17.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
5.9 | 5.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
5.8 | 23.4 | GO:0006212 | uracil catabolic process(GO:0006212) |
5.8 | 23.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
5.8 | 11.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
5.7 | 5.7 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
5.7 | 17.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
5.7 | 34.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
5.6 | 39.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
5.6 | 22.5 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
5.6 | 39.2 | GO:0070836 | caveola assembly(GO:0070836) |
5.6 | 22.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
5.5 | 16.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
5.5 | 33.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
5.5 | 16.6 | GO:0060319 | regulation of primitive erythrocyte differentiation(GO:0010725) primitive erythrocyte differentiation(GO:0060319) |
5.5 | 32.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
5.4 | 10.9 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
5.4 | 38.0 | GO:0051414 | response to cortisol(GO:0051414) |
5.3 | 26.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
5.3 | 5.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
5.3 | 31.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
5.3 | 26.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
5.2 | 15.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
5.2 | 15.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
5.2 | 15.6 | GO:0032902 | nerve growth factor production(GO:0032902) |
5.2 | 25.9 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
5.2 | 25.8 | GO:0044351 | macropinocytosis(GO:0044351) |
5.2 | 15.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
5.2 | 30.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
5.1 | 20.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
5.1 | 15.4 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
5.1 | 15.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
5.1 | 10.1 | GO:0036023 | embryonic skeletal limb joint morphogenesis(GO:0036023) |
5.0 | 10.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
5.0 | 5.0 | GO:0002084 | protein depalmitoylation(GO:0002084) |
5.0 | 15.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
5.0 | 25.1 | GO:0048539 | bone marrow development(GO:0048539) |
5.0 | 35.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
5.0 | 15.0 | GO:0061043 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
5.0 | 19.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
5.0 | 14.9 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
4.9 | 14.8 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
4.9 | 9.9 | GO:0042637 | catagen(GO:0042637) regulation of catagen(GO:0051794) |
4.9 | 4.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
4.9 | 4.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
4.8 | 14.5 | GO:0042938 | dipeptide transport(GO:0042938) |
4.8 | 14.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
4.8 | 19.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
4.8 | 28.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
4.8 | 14.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
4.7 | 28.3 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) |
4.7 | 65.9 | GO:0051639 | actin filament network formation(GO:0051639) |
4.7 | 4.7 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
4.7 | 9.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
4.7 | 37.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
4.7 | 14.0 | GO:1903116 | gastrin-induced gastric acid secretion(GO:0001698) positive regulation of actin filament-based movement(GO:1903116) |
4.6 | 9.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
4.6 | 9.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
4.6 | 9.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
4.6 | 27.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
4.5 | 18.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
4.5 | 13.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
4.5 | 9.0 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
4.5 | 9.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
4.5 | 13.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
4.5 | 31.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
4.4 | 22.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
4.4 | 17.7 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
4.4 | 53.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
4.4 | 13.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
4.4 | 35.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
4.4 | 43.8 | GO:0018158 | protein oxidation(GO:0018158) |
4.4 | 8.7 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
4.4 | 47.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
4.3 | 25.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
4.3 | 8.6 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
4.3 | 13.0 | GO:0006742 | NADP catabolic process(GO:0006742) NAD catabolic process(GO:0019677) |
4.3 | 17.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
4.3 | 25.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
4.3 | 4.3 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
4.3 | 4.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
4.2 | 25.4 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
4.2 | 8.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
4.2 | 12.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
4.2 | 33.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
4.2 | 20.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.2 | 41.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
4.2 | 8.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
4.2 | 16.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
4.2 | 33.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
4.1 | 53.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
4.1 | 20.6 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
4.1 | 16.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
4.1 | 12.3 | GO:0097187 | dentinogenesis(GO:0097187) |
4.1 | 8.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
4.1 | 4.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
4.1 | 12.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
4.1 | 28.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
4.1 | 12.2 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
4.1 | 28.5 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
4.0 | 8.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
4.0 | 4.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
4.0 | 20.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
4.0 | 4.0 | GO:0061197 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
4.0 | 24.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
4.0 | 12.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
4.0 | 12.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
4.0 | 47.8 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
4.0 | 4.0 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
4.0 | 15.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
3.9 | 47.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
3.9 | 31.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
3.9 | 7.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
3.9 | 42.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
3.9 | 27.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
3.9 | 15.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.8 | 26.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
3.8 | 26.9 | GO:0006868 | glutamine transport(GO:0006868) |
3.8 | 3.8 | GO:1905024 | regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
3.8 | 26.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
3.8 | 7.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.8 | 3.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
3.8 | 30.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
3.8 | 22.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
3.7 | 29.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
3.7 | 11.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
3.7 | 11.1 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
3.7 | 14.8 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
3.7 | 3.7 | GO:0097324 | melanocyte migration(GO:0097324) |
3.7 | 11.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
3.7 | 18.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.6 | 32.8 | GO:0060056 | mammary gland involution(GO:0060056) |
3.6 | 7.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
3.6 | 10.9 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
3.6 | 7.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
3.6 | 14.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
3.6 | 17.9 | GO:0001555 | oocyte growth(GO:0001555) |
3.6 | 17.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
3.6 | 17.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
3.5 | 10.6 | GO:0061205 | paramesonephric duct development(GO:0061205) |
3.5 | 14.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
3.5 | 77.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
3.5 | 10.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.5 | 14.0 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
3.5 | 3.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
3.5 | 14.0 | GO:1990859 | response to endothelin(GO:1990839) cellular response to endothelin(GO:1990859) |
3.5 | 13.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
3.5 | 10.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.5 | 10.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
3.4 | 3.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
3.4 | 10.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
3.4 | 13.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
3.4 | 13.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
3.4 | 13.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
3.4 | 34.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
3.4 | 27.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
3.4 | 6.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
3.4 | 6.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
3.4 | 13.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.4 | 10.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
3.4 | 13.4 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
3.4 | 6.7 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
3.3 | 33.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
3.3 | 10.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.3 | 3.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
3.3 | 6.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
3.3 | 9.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
3.3 | 19.8 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
3.3 | 9.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
3.3 | 9.9 | GO:0065001 | specification of axis polarity(GO:0065001) |
3.3 | 3.3 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
3.3 | 9.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
3.3 | 9.8 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
3.3 | 29.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
3.3 | 16.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
3.2 | 32.5 | GO:0048757 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
3.2 | 3.2 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
3.2 | 12.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
3.2 | 9.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
3.2 | 25.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
3.2 | 16.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
3.2 | 9.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
3.2 | 6.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
3.2 | 38.1 | GO:0034389 | lipid particle organization(GO:0034389) |
3.2 | 9.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
3.2 | 9.5 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.2 | 3.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
3.1 | 40.9 | GO:0003334 | keratinocyte development(GO:0003334) |
3.1 | 15.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.1 | 15.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
3.1 | 6.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
3.1 | 12.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
3.1 | 18.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
3.1 | 15.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
3.1 | 6.2 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
3.1 | 6.2 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
3.1 | 3.1 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
3.1 | 6.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
3.1 | 12.3 | GO:0009597 | detection of virus(GO:0009597) |
3.1 | 21.6 | GO:0006907 | pinocytosis(GO:0006907) |
3.1 | 18.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
3.1 | 6.2 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
3.1 | 15.4 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
3.1 | 21.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
3.1 | 9.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.1 | 12.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
3.1 | 12.3 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
3.1 | 76.6 | GO:0042554 | superoxide anion generation(GO:0042554) |
3.1 | 6.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
3.1 | 3.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
3.0 | 3.0 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) negative regulation of interleukin-17 secretion(GO:1905077) |
3.0 | 51.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
3.0 | 9.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
3.0 | 18.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
3.0 | 15.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.0 | 72.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
3.0 | 18.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
3.0 | 30.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
3.0 | 20.9 | GO:0006968 | cellular defense response(GO:0006968) |
3.0 | 29.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
3.0 | 50.6 | GO:0036336 | dendritic cell migration(GO:0036336) |
3.0 | 8.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
3.0 | 20.8 | GO:0015705 | iodide transport(GO:0015705) |
3.0 | 62.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
2.9 | 8.8 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
2.9 | 26.5 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
2.9 | 5.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
2.9 | 5.8 | GO:0061724 | lipophagy(GO:0061724) |
2.9 | 11.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.9 | 8.7 | GO:0061450 | trophoblast cell migration(GO:0061450) |
2.9 | 17.5 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
2.9 | 5.8 | GO:0030421 | defecation(GO:0030421) |
2.9 | 43.2 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
2.9 | 8.6 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
2.9 | 2.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
2.9 | 22.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
2.9 | 2.9 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) RNA repair(GO:0042245) |
2.9 | 34.3 | GO:0007097 | nuclear migration(GO:0007097) |
2.8 | 8.5 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
2.8 | 19.9 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
2.8 | 8.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.8 | 11.3 | GO:0007296 | vitellogenesis(GO:0007296) |
2.8 | 8.5 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
2.8 | 11.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.8 | 2.8 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
2.8 | 36.4 | GO:0045056 | transcytosis(GO:0045056) |
2.8 | 2.8 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
2.8 | 2.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
2.8 | 11.1 | GO:0045105 | intermediate filament polymerization or depolymerization(GO:0045105) |
2.8 | 72.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
2.8 | 11.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
2.8 | 33.1 | GO:0051014 | actin filament severing(GO:0051014) |
2.7 | 8.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
2.7 | 16.4 | GO:0033622 | integrin activation(GO:0033622) |
2.7 | 10.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.7 | 35.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.7 | 13.6 | GO:0006983 | ER overload response(GO:0006983) |
2.7 | 16.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
2.7 | 5.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
2.7 | 10.8 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
2.7 | 5.4 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
2.7 | 21.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
2.7 | 53.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
2.7 | 29.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.7 | 5.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.7 | 5.4 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
2.7 | 10.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
2.7 | 8.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.7 | 2.7 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
2.6 | 2.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.6 | 10.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.6 | 21.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
2.6 | 5.2 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
2.6 | 2.6 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
2.6 | 13.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
2.6 | 20.9 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
2.6 | 7.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.6 | 26.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
2.6 | 5.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.6 | 5.2 | GO:1904976 | cellular response to bleomycin(GO:1904976) |
2.6 | 5.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
2.6 | 7.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
2.6 | 15.5 | GO:0060721 | regulation of spongiotrophoblast cell proliferation(GO:0060721) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
2.6 | 10.3 | GO:0051958 | methotrexate transport(GO:0051958) |
2.6 | 10.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
2.6 | 20.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.6 | 5.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
2.6 | 56.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
2.5 | 5.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.5 | 10.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
2.5 | 5.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.5 | 24.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
2.5 | 10.0 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
2.5 | 14.9 | GO:0002934 | desmosome organization(GO:0002934) |
2.5 | 19.8 | GO:0048069 | eye pigmentation(GO:0048069) |
2.5 | 7.4 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
2.5 | 9.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.5 | 9.8 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
2.5 | 9.8 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
2.4 | 7.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
2.4 | 12.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.4 | 24.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.4 | 26.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
2.4 | 7.2 | GO:0009758 | carbohydrate utilization(GO:0009758) |
2.4 | 4.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.4 | 9.6 | GO:1905235 | carbohydrate export(GO:0033231) daunorubicin transport(GO:0043215) response to borneol(GO:1905230) cellular response to borneol(GO:1905231) response to codeine(GO:1905233) response to quercetin(GO:1905235) response to cyclosporin A(GO:1905237) drug transport across blood-brain barrier(GO:1990962) establishment of blood-retinal barrier(GO:1990963) |
2.4 | 4.8 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
2.4 | 7.2 | GO:0006178 | purine ribonucleoside salvage(GO:0006166) guanine salvage(GO:0006178) purine nucleobase salvage(GO:0043096) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
2.4 | 4.8 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
2.4 | 7.2 | GO:0006574 | valine catabolic process(GO:0006574) |
2.4 | 7.2 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
2.4 | 19.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
2.4 | 11.9 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
2.4 | 16.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.4 | 4.7 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
2.4 | 4.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
2.4 | 70.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
2.4 | 9.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
2.4 | 2.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.4 | 4.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
2.3 | 4.7 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.3 | 35.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
2.3 | 9.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
2.3 | 32.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.3 | 4.6 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
2.3 | 4.6 | GO:1990792 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
2.3 | 18.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.3 | 20.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
2.3 | 6.8 | GO:0046968 | cytosol to ER transport(GO:0046967) peptide antigen transport(GO:0046968) |
2.3 | 4.6 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
2.3 | 2.3 | GO:0051775 | response to redox state(GO:0051775) |
2.3 | 38.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
2.3 | 4.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
2.3 | 9.0 | GO:0032919 | spermine acetylation(GO:0032919) |
2.3 | 6.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
2.3 | 15.8 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
2.2 | 6.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.2 | 6.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
2.2 | 33.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.2 | 6.7 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) negative regulation of cell proliferation in bone marrow(GO:1903769) |
2.2 | 6.7 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.2 | 60.4 | GO:0007520 | myoblast fusion(GO:0007520) |
2.2 | 4.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
2.2 | 11.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.2 | 8.8 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
2.2 | 46.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
2.2 | 8.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) necroptotic signaling pathway(GO:0097527) |
2.2 | 17.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
2.2 | 35.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
2.2 | 4.4 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
2.2 | 6.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
2.2 | 32.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
2.2 | 13.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.2 | 10.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.2 | 6.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
2.2 | 8.6 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
2.2 | 12.9 | GO:0015074 | DNA integration(GO:0015074) |
2.1 | 21.5 | GO:0002467 | germinal center formation(GO:0002467) |
2.1 | 10.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
2.1 | 21.4 | GO:0010044 | response to aluminum ion(GO:0010044) |
2.1 | 126.2 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
2.1 | 6.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
2.1 | 21.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.1 | 2.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
2.1 | 4.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.1 | 6.4 | GO:0006083 | acetate metabolic process(GO:0006083) propionate metabolic process(GO:0019541) |
2.1 | 21.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.1 | 6.3 | GO:0010934 | macrophage cytokine production(GO:0010934) |
2.1 | 4.2 | GO:0001757 | somite specification(GO:0001757) |
2.1 | 25.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
2.1 | 6.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
2.1 | 2.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.1 | 6.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
2.1 | 4.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
2.1 | 4.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.1 | 28.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
2.1 | 8.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.0 | 16.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
2.0 | 6.1 | GO:0003383 | apical constriction(GO:0003383) |
2.0 | 4.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.0 | 14.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.0 | 24.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
2.0 | 6.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.0 | 10.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.0 | 6.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
2.0 | 24.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
2.0 | 14.0 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
2.0 | 11.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.0 | 6.0 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
2.0 | 9.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
2.0 | 27.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
2.0 | 4.0 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
2.0 | 5.9 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) negative regulation of adipose tissue development(GO:1904178) |
2.0 | 3.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.0 | 9.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
2.0 | 3.9 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
1.9 | 5.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
1.9 | 7.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.9 | 5.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.9 | 5.8 | GO:0060430 | lung saccule development(GO:0060430) |
1.9 | 27.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.9 | 5.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.9 | 7.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.9 | 7.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.9 | 9.6 | GO:0071233 | cellular response to leucine(GO:0071233) |
1.9 | 5.7 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
1.9 | 32.3 | GO:0050779 | RNA destabilization(GO:0050779) |
1.9 | 7.6 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
1.9 | 5.7 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.9 | 5.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.9 | 9.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
1.9 | 24.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.9 | 5.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.9 | 9.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.9 | 18.7 | GO:0032060 | bleb assembly(GO:0032060) |
1.9 | 104.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
1.9 | 14.9 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
1.9 | 16.7 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
1.9 | 16.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.9 | 5.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.9 | 29.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.8 | 12.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.8 | 14.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.8 | 3.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.8 | 16.4 | GO:0015886 | heme transport(GO:0015886) |
1.8 | 5.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.8 | 3.6 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
1.8 | 3.6 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
1.8 | 12.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.8 | 12.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.8 | 5.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.8 | 7.2 | GO:0071284 | cellular response to lead ion(GO:0071284) |
1.8 | 1.8 | GO:0006101 | citrate metabolic process(GO:0006101) |
1.8 | 26.9 | GO:0097320 | membrane tubulation(GO:0097320) |
1.8 | 14.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.8 | 3.6 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
1.8 | 14.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
1.8 | 5.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.8 | 5.3 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
1.8 | 33.3 | GO:0010842 | retina layer formation(GO:0010842) |
1.8 | 5.3 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.7 | 7.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
1.7 | 5.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.7 | 5.2 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.7 | 7.0 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
1.7 | 5.2 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
1.7 | 5.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.7 | 12.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.7 | 5.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.7 | 12.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.7 | 5.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.7 | 3.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.7 | 6.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.7 | 10.3 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.7 | 5.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.7 | 5.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
1.7 | 6.8 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
1.7 | 8.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.7 | 5.1 | GO:0072553 | terminal button organization(GO:0072553) |
1.7 | 5.1 | GO:0090247 | cell motility involved in somitogenic axis elongation(GO:0090247) regulation of cell motility involved in somitogenic axis elongation(GO:0090249) |
1.7 | 6.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 5.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.7 | 30.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.7 | 10.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.7 | 3.4 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
1.7 | 8.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.7 | 1.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.7 | 11.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.7 | 5.0 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) polynucleotide 5' dephosphorylation(GO:0098507) |
1.7 | 10.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
1.7 | 6.6 | GO:0046725 | negative regulation of macrophage fusion(GO:0034240) negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation by virus of viral protein levels in host cell(GO:0046725) |
1.7 | 16.6 | GO:0016266 | O-glycan processing(GO:0016266) |
1.7 | 5.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.7 | 13.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
1.6 | 6.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
1.6 | 31.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.6 | 39.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
1.6 | 14.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.6 | 1.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.6 | 9.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.6 | 8.1 | GO:0001302 | replicative cell aging(GO:0001302) |
1.6 | 6.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.6 | 1.6 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
1.6 | 8.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.6 | 8.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.6 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.6 | 6.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.6 | 6.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.6 | 12.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.6 | 3.2 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
1.6 | 7.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.6 | 11.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.6 | 11.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.6 | 9.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.6 | 4.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.6 | 12.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.6 | 15.8 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.6 | 11.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.6 | 6.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.6 | 28.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.6 | 20.3 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
1.6 | 7.8 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.6 | 4.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.5 | 9.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.5 | 13.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.5 | 4.6 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.5 | 26.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.5 | 15.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.5 | 38.1 | GO:0010761 | fibroblast migration(GO:0010761) |
1.5 | 7.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.5 | 3.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.5 | 4.6 | GO:0032218 | riboflavin transport(GO:0032218) |
1.5 | 7.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.5 | 13.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
1.5 | 1.5 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
1.5 | 10.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.5 | 68.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
1.5 | 22.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.5 | 3.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.5 | 7.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.5 | 19.3 | GO:0042407 | cristae formation(GO:0042407) |
1.5 | 3.0 | GO:0033590 | response to cobalamin(GO:0033590) |
1.5 | 5.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.5 | 1.5 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
1.5 | 10.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.5 | 31.9 | GO:0060325 | face morphogenesis(GO:0060325) |
1.4 | 10.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.4 | 28.9 | GO:0019835 | cytolysis(GO:0019835) |
1.4 | 8.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.4 | 2.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
1.4 | 5.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.4 | 21.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.4 | 8.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.4 | 4.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.4 | 4.3 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.4 | 7.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.4 | 14.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.4 | 11.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.4 | 7.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.4 | 7.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.4 | 7.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.4 | 2.8 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
1.4 | 8.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.4 | 4.2 | GO:0006567 | threonine catabolic process(GO:0006567) |
1.4 | 11.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
1.4 | 8.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.4 | 5.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.4 | 2.8 | GO:0080144 | amino acid homeostasis(GO:0080144) |
1.4 | 2.8 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
1.4 | 6.9 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
1.4 | 20.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.4 | 8.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.4 | 2.7 | GO:0034696 | response to prostaglandin F(GO:0034696) |
1.4 | 5.4 | GO:0009822 | alkaloid catabolic process(GO:0009822) isoquinoline alkaloid metabolic process(GO:0033076) |
1.4 | 4.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
1.4 | 5.4 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.4 | 1.4 | GO:0035799 | ureter maturation(GO:0035799) |
1.3 | 2.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.3 | 9.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.3 | 12.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
1.3 | 1.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.3 | 2.7 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.3 | 6.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.3 | 4.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.3 | 7.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.3 | 10.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
1.3 | 9.2 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
1.3 | 17.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
1.3 | 3.9 | GO:1903413 | cellular response to bile acid(GO:1903413) |
1.3 | 11.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
1.3 | 3.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.3 | 7.8 | GO:0000050 | urea cycle(GO:0000050) |
1.3 | 3.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.3 | 5.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.3 | 3.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.3 | 2.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
1.3 | 9.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
1.3 | 9.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.3 | 5.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.3 | 95.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
1.3 | 3.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.3 | 9.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.3 | 39.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.3 | 10.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
1.3 | 2.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.3 | 5.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.3 | 6.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.3 | 6.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.3 | 13.8 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) endothelial tube morphogenesis(GO:0061154) |
1.3 | 10.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.3 | 1.3 | GO:0003207 | cardiac chamber formation(GO:0003207) |
1.3 | 12.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.3 | 6.3 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
1.2 | 2.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.2 | 14.9 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
1.2 | 12.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.2 | 2.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.2 | 2.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
1.2 | 7.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.2 | 3.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 4.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.2 | 4.9 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
1.2 | 1.2 | GO:0021539 | subthalamus development(GO:0021539) |
1.2 | 3.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.2 | 6.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.2 | 3.6 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.2 | 2.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.2 | 36.0 | GO:0043297 | apical junction assembly(GO:0043297) |
1.2 | 7.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.2 | 10.8 | GO:0050832 | defense response to fungus(GO:0050832) |
1.2 | 5.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.2 | 14.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.2 | 15.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.2 | 2.4 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
1.2 | 5.9 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.2 | 22.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
1.2 | 2.4 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
1.2 | 3.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.2 | 15.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.2 | 11.7 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
1.2 | 11.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.2 | 1.2 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
1.2 | 3.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
1.1 | 4.6 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
1.1 | 11.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
1.1 | 18.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.1 | 3.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
1.1 | 12.5 | GO:0019076 | viral release from host cell(GO:0019076) |
1.1 | 3.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
1.1 | 4.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.1 | 4.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
1.1 | 3.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
1.1 | 3.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.1 | 13.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.1 | 4.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.1 | 13.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 2.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.1 | 1.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.1 | 3.3 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.1 | 6.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.1 | 4.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.1 | 2.2 | GO:0015746 | citrate transport(GO:0015746) |
1.1 | 3.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.1 | 7.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.1 | 5.5 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
1.1 | 7.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.1 | 4.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.1 | 18.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.1 | 6.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.1 | 4.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
1.1 | 11.7 | GO:0009635 | response to herbicide(GO:0009635) |
1.1 | 41.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.1 | 3.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.1 | 6.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
1.1 | 2.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.0 | 4.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.0 | 3.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.0 | 6.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.0 | 12.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.0 | 11.4 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
1.0 | 28.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
1.0 | 6.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.0 | 1.0 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
1.0 | 12.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.0 | 7.1 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
1.0 | 1.0 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
1.0 | 2.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.0 | 2.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.0 | 3.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.0 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.0 | 3.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.0 | 2.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.0 | 10.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.0 | 2.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.0 | 4.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
1.0 | 16.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
1.0 | 14.7 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
1.0 | 2.0 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
1.0 | 4.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.0 | 17.5 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
1.0 | 1.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.0 | 1.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
1.0 | 8.6 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
1.0 | 2.9 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.0 | 1.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 5.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.0 | 5.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.9 | 0.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.9 | 5.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.9 | 5.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.9 | 3.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.9 | 12.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.9 | 1.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.9 | 3.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 26.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.9 | 2.8 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.9 | 3.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 1.9 | GO:0072144 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.9 | 5.6 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.9 | 4.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.9 | 4.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.9 | 2.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.9 | 0.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.9 | 7.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.9 | 7.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.9 | 2.7 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.9 | 9.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.9 | 4.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.9 | 2.7 | GO:0071469 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
0.9 | 5.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.9 | 7.1 | GO:0010043 | response to zinc ion(GO:0010043) |
0.9 | 9.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.9 | 7.9 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.9 | 4.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 2.6 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.9 | 0.9 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.9 | 3.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.9 | 7.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.9 | 6.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.9 | 11.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.8 | 8.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.8 | 16.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.8 | 1.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.8 | 22.7 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.8 | 5.9 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.8 | 5.9 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
0.8 | 1.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.8 | 0.8 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.8 | 5.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.8 | 2.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.8 | 1.7 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.8 | 7.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.8 | 15.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.8 | 5.8 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.8 | 5.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.8 | 5.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 12.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.8 | 4.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.8 | 5.7 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.8 | 11.3 | GO:0071711 | basement membrane organization(GO:0071711) |
0.8 | 10.5 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.8 | 4.8 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.8 | 4.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.8 | 7.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.8 | 8.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.8 | 6.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.8 | 2.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.8 | 9.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.8 | 1.6 | GO:0035904 | aorta development(GO:0035904) |
0.8 | 1.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 3.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 5.5 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.8 | 3.9 | GO:0097435 | fibril organization(GO:0097435) |
0.8 | 6.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 7.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.8 | 1.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.8 | 10.1 | GO:0030728 | ovulation(GO:0030728) |
0.8 | 1.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.8 | 4.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.8 | 6.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.8 | 2.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 3.0 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.8 | 6.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.8 | 9.0 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.8 | 3.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 6.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.7 | 3.0 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.7 | 5.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 2.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.7 | 4.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 5.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 5.0 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.7 | 9.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.7 | 5.0 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.7 | 7.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.7 | 5.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.7 | 23.4 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
0.7 | 3.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.7 | 4.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.7 | 12.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 7.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 21.1 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.7 | 2.8 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.7 | 2.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.7 | 12.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.7 | 3.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 4.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.7 | 6.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.7 | 1.4 | GO:1900019 | hyaluronan catabolic process(GO:0030214) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.7 | 2.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 2.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.7 | 5.4 | GO:0006901 | vesicle coating(GO:0006901) |
0.7 | 7.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.7 | 5.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.7 | 2.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.7 | 4.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.7 | 2.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 25.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.7 | 4.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.7 | 0.7 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.7 | 35.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.7 | 21.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 22.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.7 | 3.3 | GO:1904401 | cellular response to Thyroid stimulating hormone(GO:1904401) |
0.7 | 20.2 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.7 | 2.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.6 | 5.2 | GO:0097205 | renal filtration(GO:0097205) |
0.6 | 3.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.6 | 11.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.6 | 4.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.6 | 0.6 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.6 | 8.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.6 | 2.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 3.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.6 | 0.6 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.6 | 12.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.6 | 21.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.6 | 5.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 2.5 | GO:0006949 | syncytium formation(GO:0006949) |
0.6 | 2.5 | GO:0042148 | strand invasion(GO:0042148) |
0.6 | 16.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.6 | 15.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.6 | 4.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.6 | 3.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 16.8 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.6 | 16.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.6 | 6.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.6 | 7.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.6 | 2.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.6 | 1.8 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.6 | 4.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 1.7 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 2.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.6 | 1.1 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.6 | 3.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.6 | 9.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 3.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 12.5 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.5 | 2.7 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.5 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 4.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.5 | 1.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 3.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.5 | 1.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 2.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 2.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 5.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.5 | 8.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 5.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 2.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 5.8 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.5 | 1.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 3.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 5.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.5 | 1.4 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 10.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.5 | 17.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.5 | 5.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.5 | 0.9 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.5 | 1.8 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 3.6 | GO:0019068 | virion assembly(GO:0019068) |
0.4 | 2.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 3.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 0.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 0.9 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 3.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 1.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.4 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 11.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 6.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.4 | 6.4 | GO:0001756 | somitogenesis(GO:0001756) |
0.4 | 4.3 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.4 | 0.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.4 | 7.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 3.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 4.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.4 | 2.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.4 | 1.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.4 | 0.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 30.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.4 | 3.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.4 | 2.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 2.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 7.7 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.4 | 4.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.7 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 6.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.4 | 0.7 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.4 | 1.1 | GO:0097332 | response to antipsychotic drug(GO:0097332) |
0.4 | 1.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 2.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.4 | 1.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 1.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 25.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.3 | 11.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.3 | 1.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 5.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.3 | 1.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 4.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 20.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 1.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.3 | 2.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 2.3 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.3 | 1.9 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 2.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.3 | 0.3 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.3 | 1.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 2.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.9 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.3 | 1.2 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.3 | 2.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.3 | 12.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.3 | 3.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.3 | 0.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 23.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 2.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 0.8 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.3 | 6.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 3.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 2.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 0.8 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 1.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 1.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 3.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 4.1 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 4.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.6 | GO:0007320 | insemination(GO:0007320) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 2.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.2 | 6.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 4.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.2 | 0.9 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 4.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 5.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 2.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 1.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 2.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 4.0 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.4 | GO:0007418 | ventral midline development(GO:0007418) |
0.2 | 2.7 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.2 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 2.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 1.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 2.6 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 1.5 | GO:0048332 | mesoderm morphogenesis(GO:0048332) |
0.2 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 6.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 2.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 0.5 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
0.1 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 8.5 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 1.1 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.7 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 1.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 2.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 1.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 1.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 2.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 1.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 2.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.7 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.6 | 43.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
13.7 | 54.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
13.5 | 67.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
13.5 | 40.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
12.3 | 36.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
12.3 | 49.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
9.8 | 49.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
9.4 | 37.7 | GO:0044393 | microspike(GO:0044393) |
9.1 | 36.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
8.8 | 70.7 | GO:0097443 | sorting endosome(GO:0097443) |
8.2 | 24.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
7.8 | 23.3 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
7.5 | 37.4 | GO:0035976 | AP1 complex(GO:0035976) |
7.0 | 20.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
6.9 | 27.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
6.9 | 34.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
6.4 | 199.0 | GO:0008305 | integrin complex(GO:0008305) |
6.4 | 38.3 | GO:0097342 | ripoptosome(GO:0097342) |
6.3 | 31.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
6.3 | 19.0 | GO:1990032 | parallel fiber(GO:1990032) |
5.9 | 23.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
5.8 | 92.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
5.7 | 57.3 | GO:0042587 | glycogen granule(GO:0042587) |
5.6 | 22.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
5.2 | 5.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
5.2 | 25.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
5.2 | 15.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
5.2 | 51.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
5.0 | 60.5 | GO:0016600 | flotillin complex(GO:0016600) |
5.0 | 45.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
4.9 | 19.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
4.8 | 33.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
4.8 | 19.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
4.7 | 23.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
4.7 | 18.9 | GO:0031904 | endosome lumen(GO:0031904) |
4.5 | 13.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
4.5 | 44.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
4.4 | 21.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
4.3 | 47.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
4.3 | 17.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
4.2 | 12.7 | GO:0005745 | m-AAA complex(GO:0005745) |
4.2 | 37.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
4.2 | 16.7 | GO:0045298 | tubulin complex(GO:0045298) |
4.2 | 12.5 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
4.1 | 16.3 | GO:0000938 | GARP complex(GO:0000938) |
3.9 | 7.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.9 | 42.9 | GO:0043219 | lateral loop(GO:0043219) |
3.9 | 11.6 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
3.8 | 91.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
3.5 | 27.9 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
3.5 | 10.4 | GO:0045242 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
3.3 | 16.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
3.3 | 286.5 | GO:0032432 | actin filament bundle(GO:0032432) |
3.3 | 10.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
3.3 | 39.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
3.3 | 32.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
3.3 | 16.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
3.2 | 9.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
3.2 | 25.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
3.2 | 9.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
3.1 | 34.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
3.1 | 9.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
3.0 | 24.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.0 | 3.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
3.0 | 5.9 | GO:0097422 | tubular endosome(GO:0097422) |
2.9 | 2.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.9 | 50.0 | GO:0031528 | microvillus membrane(GO:0031528) |
2.9 | 52.5 | GO:0005614 | interstitial matrix(GO:0005614) |
2.9 | 5.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.9 | 5.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
2.8 | 2.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.8 | 2.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
2.8 | 11.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
2.7 | 19.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.7 | 10.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
2.7 | 2.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
2.6 | 18.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.6 | 21.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.6 | 18.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.6 | 49.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.6 | 30.7 | GO:0042627 | chylomicron(GO:0042627) |
2.5 | 2.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
2.5 | 5.0 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
2.5 | 12.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
2.4 | 4.9 | GO:0043511 | inhibin complex(GO:0043511) |
2.4 | 12.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
2.4 | 16.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
2.3 | 13.9 | GO:0005915 | zonula adherens(GO:0005915) |
2.3 | 4.6 | GO:0071986 | Ragulator complex(GO:0071986) |
2.2 | 11.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.2 | 24.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.2 | 10.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.1 | 6.4 | GO:0045180 | basal cortex(GO:0045180) |
2.1 | 17.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
2.1 | 19.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
2.1 | 10.6 | GO:0043293 | apoptosome(GO:0043293) |
2.1 | 16.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
2.1 | 8.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
2.0 | 20.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
2.0 | 4.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
2.0 | 48.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.0 | 8.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.0 | 8.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.0 | 8.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.0 | 86.0 | GO:0060170 | ciliary membrane(GO:0060170) |
2.0 | 3.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
2.0 | 17.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.0 | 23.4 | GO:0042641 | actomyosin(GO:0042641) |
1.9 | 25.3 | GO:0005916 | fascia adherens(GO:0005916) |
1.9 | 9.7 | GO:0097433 | dense body(GO:0097433) |
1.9 | 36.8 | GO:0002102 | podosome(GO:0002102) |
1.9 | 17.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.9 | 26.7 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.9 | 30.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.9 | 7.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.9 | 3.7 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
1.9 | 111.9 | GO:0005902 | microvillus(GO:0005902) |
1.9 | 11.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.9 | 152.1 | GO:0031526 | brush border membrane(GO:0031526) |
1.9 | 33.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.8 | 74.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.8 | 5.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.8 | 724.5 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
1.8 | 23.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.8 | 155.8 | GO:0005604 | basement membrane(GO:0005604) |
1.8 | 3.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.7 | 8.7 | GO:1990130 | Iml1 complex(GO:1990130) |
1.7 | 7.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.7 | 5.2 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
1.7 | 3.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.7 | 5.0 | GO:0044609 | DBIRD complex(GO:0044609) |
1.7 | 5.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.7 | 5.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.7 | 8.4 | GO:0097413 | Lewy body(GO:0097413) |
1.7 | 33.2 | GO:0010369 | chromocenter(GO:0010369) |
1.6 | 17.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.6 | 4.8 | GO:0005687 | U4 snRNP(GO:0005687) |
1.6 | 12.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.6 | 26.8 | GO:0019013 | viral nucleocapsid(GO:0019013) |
1.6 | 39.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.6 | 4.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.5 | 7.7 | GO:0016342 | catenin complex(GO:0016342) |
1.5 | 10.7 | GO:0061617 | MICOS complex(GO:0061617) |
1.5 | 3.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.5 | 34.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.5 | 10.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.5 | 7.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.5 | 5.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.4 | 8.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.4 | 5.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.4 | 5.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.4 | 27.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.4 | 4.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
1.4 | 10.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.3 | 4.0 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
1.3 | 17.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.3 | 6.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.3 | 82.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.3 | 6.6 | GO:0070552 | BRISC complex(GO:0070552) |
1.3 | 11.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.3 | 4.0 | GO:0090534 | longitudinal sarcoplasmic reticulum(GO:0014801) calcium ion-transporting ATPase complex(GO:0090534) |
1.3 | 14.4 | GO:0032426 | stereocilium tip(GO:0032426) |
1.3 | 66.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.3 | 27.3 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
1.3 | 70.8 | GO:0032587 | ruffle membrane(GO:0032587) |
1.3 | 6.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.2 | 7.4 | GO:0070847 | core mediator complex(GO:0070847) |
1.2 | 8.6 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
1.2 | 32.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.2 | 55.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.2 | 77.0 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
1.2 | 244.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.2 | 8.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.2 | 52.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.2 | 4.8 | GO:0042588 | zymogen granule(GO:0042588) |
1.2 | 416.9 | GO:0031012 | extracellular matrix(GO:0031012) |
1.2 | 25.9 | GO:0005685 | U1 snRNP(GO:0005685) |
1.2 | 23.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.2 | 18.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.1 | 2.3 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
1.1 | 14.8 | GO:0005682 | U5 snRNP(GO:0005682) |
1.1 | 10.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.1 | 6.7 | GO:0001940 | male pronucleus(GO:0001940) |
1.1 | 12.2 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 370.9 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 4.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.1 | 3.3 | GO:0031415 | NatA complex(GO:0031415) |
1.1 | 60.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.1 | 5.5 | GO:1903768 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
1.1 | 5.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.1 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.1 | 262.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.1 | 24.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.1 | 11.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.1 | 7.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 12.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 3.1 | GO:0071942 | XPC complex(GO:0071942) |
1.0 | 6.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.0 | 2.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.0 | 9.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.0 | 17.5 | GO:0032420 | stereocilium(GO:0032420) |
1.0 | 4.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 4.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.0 | 5.0 | GO:0016589 | NURF complex(GO:0016589) |
1.0 | 6.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.0 | 5.0 | GO:0032059 | bleb(GO:0032059) |
1.0 | 16.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.0 | 1.0 | GO:0070820 | tertiary granule(GO:0070820) |
1.0 | 4.8 | GO:0033270 | paranode region of axon(GO:0033270) |
1.0 | 9.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 1.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.0 | 7.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.0 | 5.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.9 | 2.8 | GO:1990879 | CST complex(GO:1990879) |
0.9 | 2.8 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 3.7 | GO:0060091 | kinocilium(GO:0060091) |
0.9 | 4.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.9 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 12.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.9 | 229.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.9 | 10.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 12.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 9.4 | GO:0043218 | compact myelin(GO:0043218) |
0.9 | 10.2 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 4.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.8 | 8.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 1.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.8 | 5.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.8 | 147.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.8 | 3.2 | GO:0097196 | Shu complex(GO:0097196) |
0.8 | 55.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.8 | 1.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.8 | 14.2 | GO:0005922 | connexon complex(GO:0005922) |
0.8 | 9.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 4.7 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 6.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.8 | 4.6 | GO:0042599 | lamellar body(GO:0042599) |
0.8 | 37.4 | GO:0005776 | autophagosome(GO:0005776) |
0.8 | 64.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.8 | 3.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 23.2 | GO:0005884 | actin filament(GO:0005884) |
0.7 | 6.0 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 6.6 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 3.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 6.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 213.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.7 | 5.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 4.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 4.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 8.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 4.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.7 | 2.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 34.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 3.9 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.6 | 8.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 1.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.6 | 25.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.6 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 3.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 12.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.6 | 3.8 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.6 | 4.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.6 | 16.1 | GO:0016459 | myosin complex(GO:0016459) |
0.6 | 1152.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.6 | 1.2 | GO:0034455 | t-UTP complex(GO:0034455) |
0.6 | 1.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 15.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.5 | 24.7 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 4.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 40.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 4.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 5.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.5 | 5.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 17.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 1.9 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 5.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 4.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 1.7 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 7.1 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
0.4 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 3.2 | GO:0070161 | anchoring junction(GO:0070161) |
0.4 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 26.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.4 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 2.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 0.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 2.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 1.3 | GO:0033503 | ubiquitin conjugating enzyme complex(GO:0031371) HULC complex(GO:0033503) |
0.3 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 5.4 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 0.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.3 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 2.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 2.2 | GO:0031968 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.3 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 14.6 | GO:0005911 | cell-cell junction(GO:0005911) |
0.3 | 2.0 | GO:0031430 | M band(GO:0031430) |
0.3 | 6.6 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 2.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.2 | 2.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 3.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.2 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.2 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 2.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 6.5 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 2.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 7.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 99.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.7 | GO:0005903 | brush border(GO:0005903) |
0.1 | 4.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 141.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 1.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.1 | 66.2 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
19.5 | 97.7 | GO:0038132 | neuregulin binding(GO:0038132) |
17.8 | 53.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
16.9 | 118.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
14.3 | 42.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
13.1 | 104.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
13.0 | 104.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
12.0 | 155.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
11.7 | 35.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
9.5 | 47.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
9.1 | 27.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
9.0 | 27.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
9.0 | 27.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
9.0 | 44.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
9.0 | 26.9 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
8.9 | 35.6 | GO:0030984 | kininogen binding(GO:0030984) |
8.9 | 26.7 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
8.8 | 78.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
8.6 | 34.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
8.6 | 25.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
8.5 | 144.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
8.1 | 24.4 | GO:2001070 | starch binding(GO:2001070) |
7.9 | 23.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
7.8 | 7.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
7.7 | 30.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
7.5 | 22.5 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
7.5 | 22.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
7.1 | 21.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
7.1 | 28.6 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
7.1 | 28.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
7.1 | 21.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
7.0 | 49.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
6.8 | 27.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
6.8 | 6.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
6.7 | 20.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
6.5 | 39.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
6.5 | 52.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
6.5 | 38.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
6.4 | 64.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
6.4 | 19.3 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
6.4 | 57.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
6.3 | 82.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
6.3 | 37.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
6.2 | 24.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
6.2 | 18.6 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
6.2 | 18.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
6.2 | 43.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
6.0 | 18.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
6.0 | 35.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
6.0 | 23.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
6.0 | 23.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
5.9 | 23.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
5.8 | 23.4 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
5.8 | 40.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
5.7 | 85.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
5.7 | 137.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
5.6 | 22.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
5.6 | 16.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
5.5 | 5.5 | GO:0070538 | oleic acid binding(GO:0070538) |
5.5 | 33.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
5.5 | 60.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
5.2 | 15.7 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
5.2 | 15.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
5.1 | 10.3 | GO:0004096 | catalase activity(GO:0004096) |
5.1 | 25.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
5.1 | 20.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
5.1 | 40.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
5.0 | 20.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
5.0 | 15.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
5.0 | 15.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
4.9 | 49.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
4.9 | 19.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
4.8 | 19.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
4.8 | 14.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
4.7 | 42.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
4.7 | 14.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.7 | 23.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
4.7 | 14.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
4.6 | 13.7 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
4.5 | 18.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
4.5 | 36.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
4.5 | 67.1 | GO:0015026 | coreceptor activity(GO:0015026) |
4.4 | 48.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
4.4 | 17.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
4.4 | 17.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.3 | 13.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
4.3 | 17.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
4.3 | 17.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
4.3 | 17.2 | GO:1990254 | keratin filament binding(GO:1990254) |
4.3 | 25.8 | GO:0070728 | leucine binding(GO:0070728) |
4.3 | 106.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
4.3 | 29.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
4.2 | 25.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
4.2 | 12.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
4.2 | 54.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
4.1 | 4.1 | GO:0070976 | TIR domain binding(GO:0070976) |
4.1 | 29.0 | GO:0004064 | arylesterase activity(GO:0004064) |
4.1 | 8.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
4.1 | 8.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
4.1 | 16.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
4.1 | 12.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
4.1 | 16.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
4.0 | 11.9 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
4.0 | 7.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
4.0 | 31.7 | GO:0046790 | virion binding(GO:0046790) |
4.0 | 138.6 | GO:0043236 | laminin binding(GO:0043236) |
4.0 | 15.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
3.9 | 19.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
3.9 | 15.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.9 | 19.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.8 | 15.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.8 | 7.6 | GO:0032564 | dATP binding(GO:0032564) |
3.8 | 45.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.8 | 11.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.8 | 67.8 | GO:0044548 | S100 protein binding(GO:0044548) |
3.8 | 26.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
3.8 | 67.8 | GO:0031005 | filamin binding(GO:0031005) |
3.8 | 11.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
3.7 | 14.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
3.7 | 11.0 | GO:0016015 | morphogen activity(GO:0016015) |
3.7 | 33.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
3.6 | 10.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
3.6 | 14.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
3.6 | 50.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
3.6 | 10.7 | GO:0043398 | HLH domain binding(GO:0043398) |
3.5 | 10.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
3.5 | 14.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
3.5 | 6.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
3.5 | 13.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.5 | 10.4 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
3.4 | 10.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
3.4 | 13.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
3.4 | 27.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
3.4 | 17.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
3.4 | 10.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
3.4 | 6.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
3.4 | 23.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
3.4 | 10.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
3.4 | 27.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
3.4 | 20.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
3.4 | 20.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
3.3 | 16.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
3.3 | 40.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
3.3 | 13.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
3.3 | 19.8 | GO:0035473 | lipase binding(GO:0035473) |
3.3 | 9.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
3.3 | 19.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
3.3 | 13.1 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
3.3 | 78.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
3.2 | 19.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
3.2 | 9.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
3.2 | 9.7 | GO:0032427 | GBD domain binding(GO:0032427) |
3.2 | 35.4 | GO:0070513 | death domain binding(GO:0070513) |
3.2 | 44.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
3.2 | 25.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
3.2 | 41.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
3.2 | 15.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.1 | 9.4 | GO:0030977 | taurine binding(GO:0030977) |
3.1 | 18.8 | GO:0017040 | ceramidase activity(GO:0017040) |
3.1 | 9.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
3.1 | 15.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
3.1 | 12.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
3.1 | 24.4 | GO:0035197 | siRNA binding(GO:0035197) |
3.1 | 18.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
3.0 | 6.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
3.0 | 66.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
3.0 | 18.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
3.0 | 15.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
3.0 | 9.0 | GO:0019809 | spermidine binding(GO:0019809) |
3.0 | 9.0 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
3.0 | 21.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
3.0 | 35.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
3.0 | 53.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.9 | 26.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.9 | 26.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.8 | 5.7 | GO:0042806 | fucose binding(GO:0042806) |
2.8 | 14.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.8 | 72.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.8 | 11.1 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.8 | 63.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.8 | 16.6 | GO:0005113 | patched binding(GO:0005113) |
2.7 | 21.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.7 | 29.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.7 | 16.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
2.7 | 27.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.7 | 2.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.7 | 13.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.7 | 18.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.6 | 21.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.6 | 105.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
2.6 | 10.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
2.6 | 10.3 | GO:0045159 | myosin II binding(GO:0045159) |
2.6 | 10.3 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
2.5 | 25.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.5 | 35.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
2.5 | 12.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.5 | 19.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.5 | 9.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.5 | 9.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.5 | 63.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.5 | 12.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.5 | 9.8 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
2.4 | 7.3 | GO:0004948 | adrenomedullin receptor activity(GO:0001605) calcitonin receptor activity(GO:0004948) |
2.4 | 12.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.4 | 36.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
2.4 | 11.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
2.4 | 23.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.4 | 19.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.4 | 14.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
2.4 | 7.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
2.4 | 14.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
2.3 | 11.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.3 | 4.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.3 | 27.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.3 | 55.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.3 | 6.9 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
2.3 | 25.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
2.3 | 16.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.3 | 27.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.3 | 6.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.2 | 4.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.2 | 17.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
2.2 | 6.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.2 | 15.6 | GO:0045545 | syndecan binding(GO:0045545) |
2.2 | 8.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.2 | 11.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.2 | 28.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
2.2 | 6.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.2 | 11.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.2 | 19.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
2.2 | 6.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
2.2 | 39.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
2.2 | 4.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
2.2 | 15.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.2 | 10.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.2 | 15.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
2.2 | 15.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.1 | 12.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.1 | 59.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
2.1 | 8.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.1 | 42.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.1 | 35.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
2.1 | 35.7 | GO:0017166 | vinculin binding(GO:0017166) |
2.1 | 4.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.1 | 45.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
2.1 | 6.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.1 | 33.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
2.1 | 4.1 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) oligopeptide transmembrane transporter activity(GO:0035673) |
2.1 | 16.4 | GO:0015232 | heme transporter activity(GO:0015232) |
2.1 | 34.9 | GO:0031996 | thioesterase binding(GO:0031996) |
2.0 | 16.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
2.0 | 40.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.0 | 52.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.0 | 8.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
2.0 | 18.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.0 | 14.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
2.0 | 79.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
2.0 | 25.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
2.0 | 19.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
2.0 | 6.0 | GO:1903763 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
2.0 | 7.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.0 | 13.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.0 | 5.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
2.0 | 33.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
2.0 | 3.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.0 | 7.8 | GO:0031432 | titin binding(GO:0031432) |
2.0 | 13.7 | GO:0043495 | protein anchor(GO:0043495) |
1.9 | 17.5 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
1.9 | 7.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.9 | 5.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.9 | 5.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.9 | 15.1 | GO:0030957 | Tat protein binding(GO:0030957) |
1.9 | 5.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.9 | 9.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.9 | 5.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.8 | 9.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.8 | 7.4 | GO:0055100 | adiponectin binding(GO:0055100) |
1.8 | 9.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.8 | 3.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.8 | 16.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.8 | 11.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.8 | 5.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.8 | 5.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
1.8 | 14.5 | GO:0071253 | connexin binding(GO:0071253) |
1.8 | 14.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.8 | 7.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.8 | 3.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.8 | 7.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.7 | 5.2 | GO:0004335 | galactokinase activity(GO:0004335) |
1.7 | 8.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.7 | 133.8 | GO:0005178 | integrin binding(GO:0005178) |
1.7 | 8.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
1.7 | 19.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.7 | 5.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.7 | 29.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.7 | 13.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.7 | 6.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.7 | 18.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.7 | 11.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.7 | 5.0 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
1.7 | 18.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.7 | 8.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.7 | 5.0 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
1.7 | 5.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
1.6 | 17.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.6 | 11.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.6 | 11.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.6 | 14.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.6 | 24.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.6 | 4.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.6 | 9.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.6 | 17.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.6 | 7.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.6 | 46.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.5 | 3.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.5 | 32.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.5 | 104.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
1.5 | 4.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.5 | 20.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.5 | 62.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.5 | 4.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.5 | 6.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.5 | 4.5 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
1.5 | 22.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.5 | 5.9 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) |
1.5 | 4.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.5 | 26.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.4 | 5.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 8.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.4 | 8.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.4 | 8.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.4 | 39.5 | GO:0050699 | WW domain binding(GO:0050699) |
1.4 | 4.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.4 | 5.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.4 | 8.4 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
1.4 | 7.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.4 | 15.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.4 | 11.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.4 | 70.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.4 | 15.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.4 | 5.5 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
1.4 | 8.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.4 | 4.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.4 | 5.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.3 | 116.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.3 | 5.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.3 | 4.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.3 | 4.0 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.3 | 30.6 | GO:0035326 | enhancer binding(GO:0035326) |
1.3 | 5.3 | GO:0036122 | BMP binding(GO:0036122) |
1.3 | 5.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.3 | 14.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.3 | 36.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
1.3 | 10.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.3 | 5.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
1.3 | 5.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.3 | 7.9 | GO:0034452 | dynactin binding(GO:0034452) |
1.3 | 128.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.3 | 11.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.3 | 6.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.3 | 5.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.3 | 13.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 3.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.3 | 5.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.3 | 34.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.3 | 17.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
1.3 | 7.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.3 | 45.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.3 | 10.0 | GO:0051400 | BH domain binding(GO:0051400) |
1.3 | 10.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.2 | 23.7 | GO:0008199 | ferric iron binding(GO:0008199) |
1.2 | 14.9 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
1.2 | 32.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.2 | 2.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.2 | 4.9 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.2 | 12.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.2 | 6.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.2 | 3.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 2.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.2 | 30.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.2 | 6.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.2 | 7.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.2 | 2.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 3.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.2 | 9.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.2 | 5.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.2 | 11.8 | GO:0035198 | miRNA binding(GO:0035198) |
1.2 | 7.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.2 | 25.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.2 | 2.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
1.2 | 24.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.2 | 4.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.2 | 3.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.2 | 4.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.1 | 6.9 | GO:0048156 | tau protein binding(GO:0048156) |
1.1 | 22.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.1 | 11.4 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
1.1 | 19.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.1 | 10.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.1 | 4.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.1 | 15.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.1 | 26.8 | GO:0042805 | actinin binding(GO:0042805) |
1.1 | 8.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.1 | 12.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.1 | 3.3 | GO:0034711 | inhibin binding(GO:0034711) |
1.1 | 3.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.1 | 2.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
1.1 | 4.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.1 | 14.2 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 3.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
1.1 | 3.3 | GO:0030274 | LIM domain binding(GO:0030274) |
1.1 | 24.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
1.1 | 6.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.1 | 4.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 26.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.1 | 15.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.0 | 3.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.0 | 18.9 | GO:0005537 | mannose binding(GO:0005537) |
1.0 | 5.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.0 | 9.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.0 | 8.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.0 | 7.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 3.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.0 | 16.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.0 | 7.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.0 | 4.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.0 | 2.0 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
1.0 | 5.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.0 | 7.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
1.0 | 5.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 4.0 | GO:0032052 | bile acid binding(GO:0032052) |
1.0 | 31.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
1.0 | 3.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.0 | 2.9 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
1.0 | 8.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.0 | 22.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.0 | 10.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.0 | 11.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.0 | 119.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.0 | 15.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.0 | 3.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.0 | 100.1 | GO:0051015 | actin filament binding(GO:0051015) |
1.0 | 2.9 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
1.0 | 7.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.0 | 2.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.0 | 18.1 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 3.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.9 | 306.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.9 | 13.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.9 | 4.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.9 | 37.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.9 | 17.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.9 | 8.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.9 | 9.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.9 | 24.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.9 | 4.4 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 3.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.9 | 4.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.9 | 12.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.9 | 0.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.9 | 17.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.9 | 5.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.9 | 11.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.8 | 8.4 | GO:0019841 | retinol binding(GO:0019841) |
0.8 | 44.4 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.8 | 94.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.8 | 4.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.8 | 252.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.8 | 8.3 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.8 | 6.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.8 | 8.2 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 33.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.8 | 3.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 11.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.8 | 8.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.8 | 6.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.8 | 8.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.8 | 7.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.8 | 3.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 11.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.8 | 26.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.8 | 2.3 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.7 | 14.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.7 | 7.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 2.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.7 | 3.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.7 | 8.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.7 | 6.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.7 | 12.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.7 | 5.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.7 | 2.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 7.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.7 | 2.9 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.7 | 2.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.7 | 28.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.7 | 6.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.7 | 2.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.7 | 10.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 12.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.7 | 2.0 | GO:0015292 | uniporter activity(GO:0015292) |
0.7 | 2.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.7 | 66.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.7 | 17.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 2.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 0.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 1.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 3.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 1.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 1.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 9.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 2.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.6 | 9.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 4.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.6 | 3.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 4.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 1.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 1.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 17.5 | GO:0050661 | NADP binding(GO:0050661) |
0.6 | 5.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 1.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.6 | 4.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.6 | 17.9 | GO:0019838 | growth factor binding(GO:0019838) |
0.6 | 3.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 2.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.5 | 13.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 9.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.5 | 1.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.5 | 2.7 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
0.5 | 20.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.5 | 8.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 8.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.5 | 1.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 4.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 2.5 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 41.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.5 | 43.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.5 | 2.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 2.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 5.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 14.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.5 | 1.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 18.2 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.5 | 5.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 6.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.5 | 20.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.5 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 0.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.4 | 1.3 | GO:0009975 | cyclase activity(GO:0009975) |
0.4 | 2.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.4 | 2.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 4.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 6.9 | GO:0008252 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.4 | 6.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 1.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 2.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 4.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.4 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.4 | 11.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 1.9 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 8.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 3.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 5.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.4 | 0.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 1.0 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.3 | 3.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 0.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 3.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 4.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 4.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 6.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.3 | 55.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 8.5 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 7.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 1.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 7.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 0.8 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.3 | 4.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 13.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 3.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 8.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 4.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 3.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 3.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.8 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 87.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 5.7 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.2 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 2.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 18.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 6.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 1.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 2.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 27.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 22.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 5.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.1 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 4.8 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 3.1 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 2.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 2.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 3.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 3.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.8 | 118.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
8.3 | 241.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
6.6 | 158.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
5.1 | 148.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
4.4 | 66.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
4.4 | 52.9 | ST STAT3 PATHWAY | STAT3 Pathway |
4.3 | 121.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
4.3 | 163.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
4.1 | 12.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.9 | 207.7 | PID BMP PATHWAY | BMP receptor signaling |
3.9 | 34.7 | PID IGF1 PATHWAY | IGF1 pathway |
3.8 | 71.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
3.8 | 229.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
3.6 | 43.1 | PID EPO PATHWAY | EPO signaling pathway |
3.6 | 57.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
3.6 | 71.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
3.5 | 45.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
3.4 | 10.2 | PID IFNG PATHWAY | IFN-gamma pathway |
3.3 | 69.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
3.3 | 29.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.2 | 64.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
3.1 | 56.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
3.1 | 27.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
3.0 | 142.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
2.9 | 126.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.8 | 11.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
2.8 | 99.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
2.8 | 36.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
2.8 | 14.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.8 | 96.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
2.7 | 60.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.7 | 32.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.6 | 91.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
2.5 | 89.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
2.4 | 47.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.3 | 2.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
2.3 | 86.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.3 | 65.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
2.3 | 72.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
2.3 | 59.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
2.2 | 20.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.2 | 30.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
2.2 | 21.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.0 | 46.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.0 | 54.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
2.0 | 29.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
2.0 | 92.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.9 | 34.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.9 | 313.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.9 | 9.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.8 | 56.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.8 | 29.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.8 | 93.2 | PID NOTCH PATHWAY | Notch signaling pathway |
1.8 | 32.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.8 | 380.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.7 | 18.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.6 | 38.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.5 | 2.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.4 | 15.8 | PID ALK1 PATHWAY | ALK1 signaling events |
1.4 | 27.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.4 | 67.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.4 | 5.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.4 | 5.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.4 | 9.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.3 | 13.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.3 | 7.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.3 | 3.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.3 | 6.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.3 | 11.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.3 | 53.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.3 | 6.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.2 | 37.3 | PID FGF PATHWAY | FGF signaling pathway |
1.2 | 4.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.2 | 10.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.2 | 7.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.2 | 16.7 | PID FOXO PATHWAY | FoxO family signaling |
1.2 | 64.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.1 | 8.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.1 | 3.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.1 | 23.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.1 | 11.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.1 | 6.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.1 | 45.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.0 | 5.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.0 | 14.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.0 | 4.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.9 | 34.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 25.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.9 | 24.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.9 | 73.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.9 | 22.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.9 | 51.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.9 | 17.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.8 | 6.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 16.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 12.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 8.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.8 | 6.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 9.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 3.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 7.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.7 | 10.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 19.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.7 | 9.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.7 | 17.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 16.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.7 | 6.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.7 | 7.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.6 | 12.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 14.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 84.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 9.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 4.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 3.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 2.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 7.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 7.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 8.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 12.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 6.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 11.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 2.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 5.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 7.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 3.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 3.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 4.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 3.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 3.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.8 | 129.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
5.9 | 58.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
5.6 | 100.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
5.5 | 65.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
5.2 | 73.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
5.1 | 71.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
4.8 | 67.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
4.7 | 4.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
4.7 | 405.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
4.7 | 88.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
4.6 | 50.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
4.6 | 50.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
4.3 | 82.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
4.1 | 202.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
3.8 | 107.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
3.8 | 3.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
3.6 | 25.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
3.4 | 99.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.4 | 40.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.3 | 36.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
3.3 | 62.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
3.3 | 86.0 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
3.2 | 83.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.2 | 47.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.0 | 57.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
2.9 | 61.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.9 | 37.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
2.8 | 8.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
2.7 | 21.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.7 | 49.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.6 | 23.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
2.6 | 102.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.6 | 13.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.6 | 10.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.5 | 45.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.4 | 28.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
2.4 | 12.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
2.4 | 24.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
2.4 | 21.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.4 | 44.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
2.3 | 23.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.3 | 25.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
2.3 | 11.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.3 | 18.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
2.2 | 44.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
2.2 | 13.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.2 | 30.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.2 | 185.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
2.2 | 19.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
2.1 | 23.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.1 | 17.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
2.1 | 10.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
2.1 | 35.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
2.1 | 33.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
2.1 | 144.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.0 | 54.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.0 | 42.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
2.0 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.0 | 41.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.9 | 3.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.9 | 28.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.9 | 49.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.8 | 58.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.8 | 31.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.8 | 38.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
1.8 | 90.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.8 | 31.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.8 | 42.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.7 | 55.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.7 | 27.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.7 | 106.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.7 | 17.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.7 | 6.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.7 | 102.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.7 | 26.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
1.7 | 16.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.6 | 19.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.6 | 29.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.6 | 162.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.6 | 57.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.5 | 12.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.5 | 10.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.5 | 6.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.5 | 30.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.5 | 25.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.5 | 47.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
1.5 | 4.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
1.5 | 25.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.5 | 42.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 4.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.4 | 18.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
1.4 | 21.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.4 | 81.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.4 | 55.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.4 | 10.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.3 | 5.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.3 | 24.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
1.3 | 29.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.3 | 3.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.3 | 11.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.2 | 13.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 18.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.2 | 13.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
1.2 | 21.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.2 | 19.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.2 | 13.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.2 | 10.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 5.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.1 | 3.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.1 | 5.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.1 | 20.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.1 | 23.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.1 | 8.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.1 | 24.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.0 | 13.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 7.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.0 | 48.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.0 | 100.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.0 | 2.0 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
1.0 | 11.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.0 | 21.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.0 | 7.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.0 | 14.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
1.0 | 20.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
1.0 | 13.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.9 | 21.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.9 | 3.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.9 | 1.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.9 | 44.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.9 | 4.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.9 | 4.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.9 | 5.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.8 | 7.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 8.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 35.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.8 | 3.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.8 | 9.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.8 | 4.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 14.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 5.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.7 | 13.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 7.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.7 | 8.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 12.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.7 | 12.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 4.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 6.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 7.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 65.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.6 | 6.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 3.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.6 | 6.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 12.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 13.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 35.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.5 | 4.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 4.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 7.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 2.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.5 | 17.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 3.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 5.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 1.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 10.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.4 | 6.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 3.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.4 | 3.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 10.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 3.6 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.4 | 1.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 2.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.3 | 1.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 8.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 8.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 1.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 3.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 10.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 3.6 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.3 | 7.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 5.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 6.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 2.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 2.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 4.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 13.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 9.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 2.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |